Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ: LMRI · Real-Time Price · USD
10.75
-0.38 (-3.41%)
Jul 22, 2026, 3:36 PM EDT - Market open
Lumexa Imaging Holdings Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Lumexa Imaging Holdings stock has a consensus rating of "Strong Buy" and an average price target of $17.29. The average 1-year stock price forecast is 60.84% higher than the current stock price, while the lowest is $9.00 (-16.28%) and the highest is $23 (+113.95%).
Price Target: $17.29 (+60.84%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 18, 2026.
Analyst Ratings
The average analyst rating for Lumexa Imaging Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Reiterates $17 | Buy | Reiterates | $17 | +58.14% | Jun 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $18 | Buy | Maintains | $18 | +67.44% | May 25, 2026 |
| Barclays | Barclays | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | -16.28% | May 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +76.74% | May 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
Financial Forecast
Revenue This Year
1.07B
from 1.02B
Increased by 4.25%
Revenue Next Year
1.12B
from 1.07B
Increased by 5.47%
EPS This Year
0.71
from 0.18
Increased by 293.15%
EPS Next Year
0.90
from 0.71
Increased by 27.50%
EPS and Forward PE are based on non-GAAP adjusted numbers.